LoginSubscribe DatabaseScreen Shots


James Hall Joins Immunovaccine Board of Directors

TechFinance.ca News
Tuesday February 23, 2010

Immunovaccine Inc. (TSX-V: IMV) has appointed James W. Hall, C.A. to its board of directors. Hall will serve as ch...



[ ... to read the whole article, subscription is required ... ]



... ... Hall currently serves on the board of directors of Indigo books & Music Inc., Global Credit Pref Corp., Adventus I...


To read this or any other article, or trial test our database, please try our 7 days or 1 month subscription, Click Here for Details.





Company Deals and People
Date
Title
Type
2010/8/12
Financing
2010/2/23
Director
2009/10/2
ImmunoVaccine Technologies Goes Public on TSX Venture
RTO, QT
2009/10/2
Financing
2009/9/28
Management
2008/1/21
ACOA Invests in ImmunoVaccine Technologies
Financing
2007/12/7
ImmunoVaccine Technologies Raises Additional Funds
Financing
2007/4/20
ImmunoVaccine Technologies Closes Financing
Financing
2006/8/3
ImmunoVaccine Technologies Closes Financing
Financing
2005/4/1
ImmunoVaccine Technologies Secures Financing
Financing

 
ImmunoVaccine Inc.
TSX-V: IMV
formerly: ImmunoVaccine Technologies Inc.
» To this firm page « (subscriber only)
1819 Granville Street, Suite 303
Halifax, NS   B3J 3R1
Tel:  (902) 492-1819
Fax:  (902) 492-0888
http://www.immunovaccine.com
Sector - Biotechnology, Biopharmaceuticals
Business Description
ImmunoVaccine is a developer of proprietary vaccine technology, VacciMax®, which can be applied to most human and veterinary vaccines.


Company News
James Hall Joins Immunovaccine Board of Directors 2010/2/23